NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Nuvalent Inc. Class A Common Stock (NASDAQ: NUVL)
NUVL Technical Analysis
5
As on 9th Jun 2023 NUVL STOCK Price closed @ 41.82 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 16.23 & Strong Buy for SHORT-TERM with Stoploss of 15.80 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NUVLSTOCK Price
Open | 42.68 | Change | Price | % |
High | 42.92 | 1 Day | -0.67 | -1.58 |
Low | 41.42 | 1 Week | -0.28 | -0.67 |
Close | 41.82 | 1 Month | 7.47 | 21.75 |
Volume | 184321 | 1 Year | 21.15 | 102.32 |
52 Week High 44.59 | 52 Week Low 7.40 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
NUVL Daily Charts |
NUVL Intraday Charts |
Whats New @ Bazaartrend |
NUVL Free Analysis |
|
NUVL Important Levels Intraday
RESISTANCE | 44.71 |
RESISTANCE | 43.78 |
RESISTANCE | 43.21 |
RESISTANCE | 42.64 |
SUPPORT | 41.00 |
SUPPORT | 40.43 |
SUPPORT | 39.86 |
SUPPORT | 38.93 |
NUVL Forecast April 2024
4th UP Forecast | 58.06 |
3rd UP Forecast | 52.85 |
2nd UP Forecast | 49.63 |
1st UP Forecast | 46.41 |
1st DOWN Forecast | 37.23 |
2nd DOWN Forecast | 34.01 |
3rd DOWN Forecast | 30.79 |
4th DOWN Forecast | 25.58 |
NUVL Weekly Forecast
4th UP Forecast | 47.18 |
3rd UP Forecast | 45.46 |
2nd UP Forecast | 44.40 |
1st UP Forecast | 43.34 |
1st DOWN Forecast | 40.30 |
2nd DOWN Forecast | 39.24 |
3rd DOWN Forecast | 38.18 |
4th DOWN Forecast | 36.46 |
NUVL Forecast2024
4th UP Forecast | 115.18 |
3rd UP Forecast | 91.65 |
2nd UP Forecast | 77.11 |
1st UP Forecast | 62.57 |
1st DOWN Forecast | 21.07 |
2nd DOWN Forecast | 6.53 |
3rd DOWN Forecast | -8.01 |
4th DOWN Forecast | -31.54 |
Nuvalent Inc. Class A Common Stock ( NASDAQ USA Symbol : NUVL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NUVL Other Details
Segment | EQ | |
Market Capital | 1164610176.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
NUVL Address
NUVL Latest News
NUVL Business Profile
Nuvalent, Inc., a preclinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor, designed to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and also remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors; and NVL-655, a brain-penetrant ALK-selective inhibitor, designed to inhibit ALK fusions that express the normal ALK kinase domain without any drug-resistant mutations and also remain active in the presence of mutations conferring resistance to first, second, and third generation ALK inhibitors. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Address: One Broadway, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service